Q3 2023
Released Nov 9, 2023, before the open
10-Q filed Nov 13, 2023, 44 days after period end · 0000868278-23-000017
Q3 2023 · 10-Q
Revenue$8.37M$8.37M −65.4% vs Q3 2022−36.7% vs Q2 2023
Net Income-$5.14M-$5.14M N/M vs Q3 2022N/M vs Q2 2023
EPS Diluted-$0.30-$0.30 N/M vs Q3 2022N/M vs Q2 2023
Gross Profit$2,327,000−80.6%
Operating Income-$6,478,000N/M
Operating Cash Flowderived-$4,654,000N/M
Free Cash Flowderived-$5,322,000N/M
Margins · derived
Gross margin27.8%−21.7 pt vs Q3 2022
Operating margin-77.4%−85.5 pt vs Q3 2022
Net margin-61.5%−65.5 pt vs Q3 2022
What the release said
The release
Same quarter
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $8.37M | $24.20M | $9.47M | $3.84M |
| Net Income | -$5.14M | $968.00K | -$3.98M | -$408.00K |
| EPS Diluted | -$0.30 | $0.06 | -$0.26 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR